146 related articles for article (PubMed ID: 31515975)
1. In vitro study of synergy of ampicillin with ceftriaxone against Listeria monocytogenes.
Lepe JA; Rodríguez-Villodres A; Martín-Gutiérrez G; Luque R; Aznar J
Rev Esp Quimioter; 2019 Oct; 32(5):465-468. PubMed ID: 31515975
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
Werth BJ; Shireman LM
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
[TBL] [Abstract][Full Text] [Related]
3. Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates.
Cusumano JA; Khan R; Shah Z; Philogene C; Harrichand A; Huang V
Microbiol Spectr; 2022 Aug; 10(4):e0062122. PubMed ID: 35703558
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium.
Lorenzo MP; Kidd JM; Jenkins SG; Nicolau DP; Housman ST
J Antimicrob Chemother; 2019 Aug; 74(8):2269-2273. PubMed ID: 31050740
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro activity of ampicillin and moxifloxacin against Listeria monocytogenes at achievable concentrations in the central nervous system.
Pupo I; Lepe JA; Smani Y; Aznar J
J Med Microbiol; 2017 Jun; 66(6):713-720. PubMed ID: 28598305
[TBL] [Abstract][Full Text] [Related]
6. Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens.
Hoogkamp-Korstanje JA
J Antimicrob Chemother; 1985 Sep; 16(3):327-34. PubMed ID: 3932295
[TBL] [Abstract][Full Text] [Related]
7. Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies.
Kumaraswamy M; Do C; Sakoulas G; Nonejuie P; Tseng GW; King H; Fierer J; Pogliano J; Nizet V
Int J Antimicrob Agents; 2018 Mar; 51(3):468-478. PubMed ID: 29337066
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic synergism against Listeria monocytogenes.
Moellering RC; Medoff G; Leech I; Wennersten C; Kunz LJ
Antimicrob Agents Chemother; 1972 Jan; 1(1):30-4. PubMed ID: 4207757
[TBL] [Abstract][Full Text] [Related]
9. [Resistance of Listeria monocytogenes to cefotaxime and ceftriaxone combined with an aminoside].
Borderon E; Borderon JC; Feron JF; Thieffry JC; Tescher M; Farid IA
Pathol Biol (Paris); 1987 May; 35(5):568-71. PubMed ID: 3112709
[TBL] [Abstract][Full Text] [Related]
10. In-vitro synergy testing of nine antimicrobial combinations against Listeria monocytogenes.
MacGowan AP; Holt HA; Reeves DS
J Antimicrob Chemother; 1990 Apr; 25(4):561-6. PubMed ID: 2112538
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of clinical isolates of Listeria monocytogenes.
Wiggins GL; Albritton WL; Feeley JC
Antimicrob Agents Chemother; 1978 May; 13(5):854-60. PubMed ID: 96737
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of ampicillin-ceftriaxone against Enterococcus faecalis isolates recovered from invasive infections].
Burguer Moreira N; Nastro M; Vay C; Famiglietti Á; Rodríguez CH
Rev Argent Microbiol; 2016; 48(1):57-61. PubMed ID: 26857425
[TBL] [Abstract][Full Text] [Related]
13. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
[TBL] [Abstract][Full Text] [Related]
15. Effect of subinhibitory concentrations of ampicillin on Listeria monocytogenes.
Rodríguez-Villodres Á; Lepe JA; Blázquez J; Aznar J
Enferm Infecc Microbiol Clin (Engl Ed); 2020 Feb; 38(2):72-75. PubMed ID: 31027868
[TBL] [Abstract][Full Text] [Related]
16. Ampicillin-aminoglycoside interaction studies using Listeria monocytogenes.
MacGowan A; Wootton M; Bowker K; Holt HA; Reeves D
J Antimicrob Chemother; 1998 Mar; 41(3):417-8. PubMed ID: 9578172
[No Abstract] [Full Text] [Related]
17. Synergistic antibacterial effect of apigenin with β-lactam antibiotics and modulation of bacterial resistance by a possible membrane effect against methicillin resistant Staphylococcus aureus.
Akilandeswari K; Ruckmani K
Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):74-82. PubMed ID: 28145860
[TBL] [Abstract][Full Text] [Related]
18. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
Ozseven AG; Sesli Çetin E; Ozseven L
Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility and synergy of clinical isolates of Listeria monocytogenes.
Tuazon CU; Shamsuddin D; Miller H
Antimicrob Agents Chemother; 1982 Mar; 21(3):525-7. PubMed ID: 6808911
[TBL] [Abstract][Full Text] [Related]
20. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
